Pfizer Inc. Stock Has a Great Storyline That’s Not Panning OutAt first glance, Pfizer Inc. (NYSE:PFE) appears a worthwhile contrarian trade. Additionally, the overall markets have been soft, allowing shrewd investors to pick up PFE stock at a more attractive valuation. As a result, many analysts are questioning whether Pfizer stock, at its present cost, is worth the risk.


Read More At Article Source | Article Attribution